GENERAL
Trump Hints at Psychedelic Drug Research Reforms
The Trump administration has announced plans to reform policies, aiming to speed up access to research and treatments involving psychedelic drugs. These substances show promise for severe mental illness and addiction, with specific mention of ibogaine helping over 80% of people overcome opioid addiction after one dose. This signals a potential major shift in federal approach to these therapies, particularly for veterans.